Should I buy Salesforce (CRM) stock or is it too late?

Salesforce · Information Technology · price $252
Logo SalesforceSee the full Salesforce (CRM) profile
⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: BTIG82% of its targets hit on this sector (67 calls tested). It aims for $255 (+1.2 %), call made on August 25, 2026, maturing on August 25, 2027 (3 d ago).

The 11 reliable analysts $228-9.5 %
The 13 other firms $236-6.4 %
How to read it: the 11 reliable firms are not filtered by optimism — 2 aim above the price, 9 below, hence their $228 median. “The 13 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Salesforce

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.
Firm% rightGain vs sectorCallsAims for
Keybanc100 %+33.7 %7$290 +15%
Wells Fargo86 %+28.4 %14$205 -19%
Citigroup89 %+25.6 %9$204 -19%
Wedbush68 %+21.0 %22$325 +29%
Macquarie100 %+21.0 %8$190 -25%
Barclays70 %+17.0 %37$236 -6%
Evercore ISI Group70 %+16.6 %10$250 -1%
RBC Capital64 %+14.7 %22$420 +67%
In short — Should you invest in Salesforce? Is it too late, still worth it? Analysts are fairly positive (57% buy, median target $229, i.e. -9%), and the most reliable on CRM targets even higher. But the stock is volatile. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

  • The most reliable firm on CRM, Keybanc (100% hit rate, 7 scored calls), targets $290 (call made on May 28, 2026, maturing on May 28, 2027) (+15%) in its most recent call.
  • Reasonable valuation (P/E ~19) relative to its sector.

⚠️ Reasons to hesitate

  • The consensus is not unanimous: of 23 ratings, 9 are neutral and 1 is a sell.
  • Limited upside: the median target is only -9% from the current price.
  • A 12-month target is not a guaranteed path: the price can fall in the meantime.
  • Volatile stock: sharp swings — including steep drops — are part of its profile.

The analyst consensus on CRM

Median target $229 (-9%) · 23 ratings · Buy consensus

Strong Buy00%
Buy1357%
Hold939%
Sell14%
Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Salesforce now?

We won't decide for you. The facts: 57% of analysts rate it a buy, median target $229 (-9%), and Keybanc (most reliable on CRM, 100%) targets $290. Weigh that against valuation (P/E ~19) and volatility. This is not personalized advice.

Is it too late to invest in Salesforce?

The stated upside is small: the median target ($229) sits just -9% from the price ($252) (most reliable on CRM: Keybanc, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Salesforce still worth investing in?

It depends on the gap between the price ($252) and its estimated value: analysts target $229 on median (-9%), with 57% buys (most reliable on CRM: Keybanc, 100%). Cross-check with their real reliability on CRM and the cautions above. Information, not advice.

What's the main risk in buying CRM?

The consensus is not unanimous: of 23 ratings, 9 are neutral and 1 is a sell.

→ Go deeper: the full Salesforce profile (consensus, analyst reliability, price target, performance).

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)